{
    "hands_on_practices": [
        {
            "introduction": "Understanding the speed at which an infection can develop is fundamental to clinical microbiology. This first practice models the initial, exponential growth phase of bacteria in the lungs during the onset of pneumonia, before the immune system can mount an effective response. By applying a basic differential equation, you will calculate the time it takes for a small bacterial inoculum to reach a clinically significant population, providing a quantitative appreciation for the urgency of diagnosis and treatment .",
            "id": "4621545",
            "problem": "In early bacterial pneumonia, before host defenses substantially alter growth dynamics, the bacterial population in the alveolar space can be approximated as growing under constant conditions with a size-proportional rate. The fundamental base for this model is that the instantaneous rate of change of the population size is proportional to its current size with a constant per-capita rate under fixed environmental conditions. Specifically, assume the per-capita growth rate is constant and equal to $r$, and the initial condition at $t=0$ is a single well-mixed inoculum of $N_{0}$ colony-forming units (CFU). The clinically relevant threshold for overt pneumonia is reached when the population attains $N$ CFU.\n\nUsing only the stated base (that the instantaneous rate of change is proportional to population size with constant per-capita rate), derive the time $t$ required for the bacterial population to grow from $N_{0}$ to $N$ under these early-phase conditions. Then evaluate your expression for the following scientifically plausible parameters for pneumococcal growth in alveolar fluid: initial inoculum $N_{0} = 2.5 \\times 10^{4}$ CFU, threshold $N = 1.0 \\times 10^{9}$ CFU, and net per-capita growth rate $r = 0.80 \\ \\mathrm{h}^{-1}$. Assume uniform mixing, adequate nutrients, constant temperature, and negligible immune clearance or spatial limitation up to the threshold $N$. Express the final time in hours and round your answer to four significant figures.",
            "solution": "The fundamental base states that under fixed environmental conditions in the early phase of infection, the instantaneous rate of change of population size is proportional to the current population size with a constant per-capita rate. Denoting the population size by $N(t)$ and the constant per-capita rate by $r$, this base is represented mathematically by the first-order ordinary differential equation\n$$\n\\frac{dN}{dt} = r N.\n$$\nThis equation encodes that the per-capita growth rate is constant and the environment is not yet limiting. We are given the initial condition $N(0) = N_{0}$ and we seek the time $t$ such that $N(t) = N$.\n\nTo derive $t$ from first principles, we use separation of variables. Rewrite the differential equation as\n$$\n\\frac{1}{N} \\, dN = r \\, dt.\n$$\nIntegrate both sides from the initial state to the threshold state and from time $0$ to time $t$:\n$$\n\\int_{N_{0}}^{N} \\frac{1}{N'} \\, dN' = \\int_{0}^{t} r \\, dt'.\n$$\nThe left-hand side evaluates to $\\ln(N) - \\ln(N_{0}) = \\ln\\!\\left(\\frac{N}{N_{0}}\\right)$, and the right-hand side evaluates to $r t$. Therefore,\n$$\n\\ln\\!\\left(\\frac{N}{N_{0}}\\right) = r t,\n$$\nwhich yields the general expression for the time to reach $N$ from $N_{0}$ under exponential growth:\n$$\nt = \\frac{1}{r} \\, \\ln\\!\\left(\\frac{N}{N_{0}}\\right).\n$$\n\nNow evaluate this expression with the given parameters $N_{0} = 2.5 \\times 10^{4}$, $N = 1.0 \\times 10^{9}$, and $r = 0.80 \\ \\mathrm{h}^{-1}$. First compute the ratio:\n$$\n\\frac{N}{N_{0}} = \\frac{1.0 \\times 10^{9}}{2.5 \\times 10^{4}} = 4.0 \\times 10^{4}.\n$$\nThen take the natural logarithm:\n$$\n\\ln\\!\\left(4.0 \\times 10^{4}\\right) = \\ln(4) + \\ln\\!\\left(10^{4}\\right) = \\ln(4) + 4 \\ln(10).\n$$\nUsing well-known constants, $\\ln(4) \\approx 1.386294361$ and $\\ln(10) \\approx 2.302585093$, we obtain\n$$\n\\ln\\!\\left(4.0 \\times 10^{4}\\right) \\approx 1.386294361 + 4 \\times 2.302585093 = 1.386294361 + 9.210340372 = 10.596634733.\n$$\nFinally, compute the time:\n$$\nt = \\frac{1}{0.80} \\times 10.596634733 = 1.25 \\times 10.596634733 = 13.245793416.\n$$\nRounded to four significant figures and expressed in hours, the time is $13.25$ hours.",
            "answer": "$$\\boxed{13.25}$$"
        },
        {
            "introduction": "After recognizing the signs of a potential infection, the next critical step is accurate diagnosis. This exercise challenges you to evaluate the performance of a modern molecular diagnostic test for pneumonia by calculating its sensitivity, specificity, and predictive values from a validation dataset. You will then use these performance metrics to apply Bayes' theorem, a cornerstone of medical decision-making, to determine the actual probability of disease after a positive test result .",
            "id": "4621580",
            "problem": "A tertiary hospital evaluates a rapid pneumonia pathogen multiplex polymerase chain reaction (PCR) panel against a composite clinical and microbiologic reference standard in adults admitted with suspected community-acquired pneumonia. Among $N$ consecutive patients, the following $2 \\times 2$ classification was obtained by adjudication: true positives $=$ $110$, false negatives $=$ $10$, false positives $=$ $15$, true negatives $=$ $85$. Using only fundamental definitions of diagnostic accuracy and Bayesâ€™ theorem expressed via odds, do the following: compute the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of the panel; then derive the positive likelihood ratio and negative likelihood ratio from these quantities; finally, in an urgent care setting where the pre-test probability of bacterial pneumonia among similar patients is estimated at $0.35$, compute the post-test probability of pneumonia after a positive panel result. Round your final numerical answer to four significant figures and express it as a decimal (do not use a percentage sign). For grading, report only the final post-test probability after a positive result.",
            "solution": "The problem requires the calculation of a post-test probability of disease given a positive test result, based on a provided $2 \\times 2$ classification table for a new diagnostic test and a specified pre-test probability. The solution must proceed by first computing standard measures of diagnostic accuracy (sensitivity, specificity, predictive values), then deriving likelihood ratios, and finally applying Bayes' theorem in its odds-based form.\n\nFirst, we formalize the provided data. Let $D+$ denote the presence of disease (pneumonia) and $D-$ denote its absence. Let $T+$ denote a positive test result and $T-$ denote a negative test result. The given data points are:\n- True Positives (TP): The number of individuals with the disease who test positive. $TP = 110$.\n- False Negatives (FN): The number of individuals with the disease who test negative. $FN = 10$.\n- False Positives (FP): The number of individuals without the disease who test positive. $FP = 15$.\n- True Negatives (TN): The number of individuals without the disease who test negative. $TN = 85$.\n\nFrom these fundamental counts, we can calculate the marginal totals:\n- Total number of individuals with the disease: $N_{D+} = TP + FN = 110 + 10 = 120$.\n- Total number of individuals without the disease: $N_{D-} = FP + TN = 15 + 85 = 100$.\n- Total number of individuals with a positive test: $N_{T+} = TP + FP = 110 + 15 = 125$.\n- Total number of individuals with a negative test: $N_{T-} = FN + TN = 10 + 85 = 95$.\n- Total number of patients in the study: $N = TP + FN + FP + TN = 110 + 10 + 15 + 85 = 220$.\n\nThe first step is to compute the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV).\n\n1.  **Sensitivity (Sens)** is the probability of a positive test given that the patient has the disease, $P(T+|D+)$.\n    $$ \\text{Sens} = \\frac{TP}{TP + FN} = \\frac{110}{120} = \\frac{11}{12} $$\n\n2.  **Specificity (Spec)** is the probability of a negative test given that the patient does not have the disease, $P(T-|D-)$.\n    $$ \\text{Spec} = \\frac{TN}{TN + FP} = \\frac{85}{100} = 0.85 = \\frac{17}{20} $$\n\n3.  **Positive Predictive Value (PPV)** is the probability that a patient has the disease given a positive test result, $P(D+|T+)$.\n    $$ \\text{PPV} = \\frac{TP}{TP + FP} = \\frac{110}{125} = \\frac{22}{25} = 0.88 $$\n\n4.  **Negative Predictive Value (NPV)** is the probability that a patient does not have the disease given a negative test result, $P(D-|T-)$.\n    $$ \\text{NPV} = \\frac{TN}{TN + FN} = \\frac{85}{95} = \\frac{17}{19} $$\n\nThe next step is to derive the positive and negative likelihood ratios from sensitivity and specificity.\n\n5.  **Positive Likelihood Ratio (LR+)** is the ratio of the probability of a positive test in a diseased individual to the probability of a positive test in a non-diseased individual. It is derived from sensitivity and specificity as follows:\n    $$ LR+ = \\frac{P(T+|D+)}{P(T+|D-)} = \\frac{\\text{Sens}}{1 - \\text{Spec}} $$\n    Substituting the calculated values:\n    $$ LR+ = \\frac{11/12}{1 - 17/20} = \\frac{11/12}{3/20} = \\frac{11}{12} \\times \\frac{20}{3} = \\frac{11 \\times 5}{3 \\times 3} = \\frac{55}{9} $$\n\n6.  **Negative Likelihood Ratio (LR-)** is the ratio of the probability of a negative test in a diseased individual to the probability of a negative test in a non-diseased individual.\n    $$ LR- = \\frac{P(T-|D+)}{P(T-|D-)} = \\frac{1 - \\text{Sens}}{\\text{Spec}} $$\n    Substituting the calculated values:\n    $$ LR- = \\frac{1 - 11/12}{17/20} = \\frac{1/12}{17/20} = \\frac{1}{12} \\times \\frac{20}{17} = \\frac{5}{3 \\times 17} = \\frac{5}{51} $$\n\nThe final step is to compute the post-test probability of pneumonia after a positive panel result in a different setting where the pre-test probability is given. We must use Bayes' theorem expressed in terms of odds.\n\nThe given pre-test probability of pneumonia is $P(\\text{D+}) = 0.35$.\nThe pre-test odds of having the disease are defined as the ratio of the probability of having the disease to the probability of not having it:\n$$ \\text{Pre-test odds} = \\frac{P(\\text{D+})}{1 - P(\\text{D+})} = \\frac{0.35}{1 - 0.35} = \\frac{0.35}{0.65} = \\frac{35}{65} = \\frac{7}{13} $$\n\nBayes' theorem in odds form states that the post-test odds are the product of the pre-test odds and the likelihood ratio for the given test result. Since the test result is positive, we use the positive likelihood ratio (LR+):\n$$ \\text{Post-test odds} = \\text{Pre-test odds} \\times LR+ $$\nSubstituting the values:\n$$ \\text{Post-test odds} = \\frac{7}{13} \\times \\frac{55}{9} = \\frac{385}{117} $$\n\nFinally, we convert the post-test odds back to a probability. The relationship between probability ($p$) and odds ($o$) is $p = \\frac{o}{1+o}$.\nThe post-test probability of disease given a positive test, $P(D+|T+)$, is:\n$$ P(D+|T+) = \\frac{\\text{Post-test odds}}{1 + \\text{Post-test odds}} = \\frac{385/117}{1 + 385/117} = \\frac{385/117}{(117+385)/117} = \\frac{385}{502} $$\n\nTo obtain the final numerical answer, we compute the decimal value of this fraction and round it to four significant figures as requested.\n$$ \\frac{385}{502} \\approx 0.76693227... $$\nRounding to four significant figures gives $0.7669$.",
            "answer": "$$\\boxed{0.7669}$$"
        },
        {
            "introduction": "Once a bacterial infection is diagnosed, effective treatment requires a dosing strategy tailored to both the pathogen and the drug's properties. This practice delves into the principles of pharmacokinetics and pharmacodynamics (PK/PD) for beta-lactam antibiotics, which exhibit time-dependent killing. You will work with the crucial parameter $fT_{>\\text{MIC}}$, the fraction of time the drug concentration remains above the pathogen's Minimum Inhibitory Concentration, to determine an optimal dosing frequency for treating pneumonia .",
            "id": "4621538",
            "problem": "A hospitalized adult with community-acquired pneumonia due to a beta-lactam-susceptible Streptococcus pneumoniae is treated with an intravenous beta-lactam. In time-dependent antibacterials such as beta-lactams, bactericidal efficacy correlates with the fraction of the dosing interval during which the free (unbound) drug concentration at the infection site exceeds the Minimum Inhibitory Concentration (MIC), a parameter denoted $fT_{>\\text{MIC}}$. Using the following foundational bases and data, derive the quantitative relationship connecting $fT_{>\\text{MIC}}$ to bactericidal effect for beta-lactams in pneumonia, and then compute the minimal dosing frequency needed to achieve $fT_{>\\text{MIC}} \\ge 0.50$ (that is, at least fifty percent of each dosing interval) in the alveolar Epithelial Lining Fluid (ELF):\n\nFoundational bases permitted:\n- The Minimum Inhibitory Concentration (MIC) is the lowest concentration of an antimicrobial that inhibits visible growth, and for time-dependent antibacterials the net bactericidal effect over a dosing interval increases monotonically with the measure of time during which the free concentration at the infection site is above the MIC.\n- One-compartment pharmacokinetics with first-order elimination is assumed: after a single intravenous bolus dose $D$, the plasma concentration is $C(t) = \\dfrac{D}{V_d} \\exp(-k t)$, where $V_d$ is the apparent volume of distribution and $k$ is the first-order elimination rate constant related to the half-life $t_{1/2}$ by $k = \\dfrac{\\ln 2}{t_{1/2}}$. Superposition applies for repeated dosing at interval $\\tau$.\n- The infection-site free concentration in the alveolar Epithelial Lining Fluid (ELF) is modeled as $C_{\\text{ELF,free}}(t) = f_u \\, r \\, C(t)$, where $f_u$ is the free (unbound) fraction in plasma and $r$ is the ELF-to-plasma concentration ratio.\n\nGiven data:\n- Dose $D = 1.0 \\times 10^{3} \\,\\mathrm{mg}$ (intravenous bolus)\n- Body mass $= 70 \\,\\mathrm{kg}$\n- Apparent volume of distribution $V_d = 0.20 \\,\\mathrm{L/kg} \\times 70 \\,\\mathrm{kg} = 14 \\,\\mathrm{L}$\n- Half-life $t_{1/2} = 2.0 \\,\\mathrm{h}$, so $k = \\dfrac{\\ln 2}{2.0 \\,\\mathrm{h}}$\n- Protein binding $= 40\\%$, so $f_u = 0.60$\n- ELF-to-plasma ratio $r = 0.50$\n- MIC for the pathogen in ELF $= 2.0 \\,\\mathrm{mg/L}$\n\nTasks:\n1. Using the bases above, derive an expression showing that for beta-lactams with time-dependent killing, the net bactericidal efficacy over a dosing interval is an increasing function of $fT_{>\\text{MIC}}$, and that the target $fT_{>\\text{MIC}} \\ge 0.50$ is mechanistically consistent with maintaining free ELF concentrations above MIC for at least half of each dosing interval.\n2. At pharmacokinetic steady state under repeated dosing every $\\tau$ hours, derive an expression for $fT_{>\\text{MIC}}$ for this regimen in terms of $D$, $V_d$, $f_u$, $r$, $\\text{MIC}$, $k$, and $\\tau$.\n3. Solve for the minimal dosing interval $\\tau$ that achieves $fT_{>\\text{MIC}} = 0.50$, and convert it to the minimal dosing frequency per day $n = \\dfrac{24 \\,\\mathrm{h}}{\\tau}$.\nExpress the final dosing frequency in $\\mathrm{day}^{-1}$ and round your answer to three significant figures.",
            "solution": "**Task 1: Conceptual Basis of the $fT_{>\\text{MIC}}$ Target**\n\nThe problem states as a foundational basis that for time-dependent antibacterials like beta-lactams, the net bactericidal effect over a dosing interval, let's call it $E$, increases monotonically with the measure of time during which the free drug concentration at the infection site is above the Minimum Inhibitory Concentration (MIC). This measure is denoted $fT_{>\\text{MIC}}$. Mathematically, this relationship can be expressed as $E = g(fT_{>\\text{MIC}})$, where $g$ is a monotonically increasing function.\n\nThe term $fT_{>\\text{MIC}}$ is defined as the fraction of the dosing interval, $\\tau$, during which the free drug concentration at the infection site, $C_{\\text{ELF,free}}(t)$, exceeds the MIC. If we define $T_{>\\text{MIC}}$ as the total time within the interval $[0, \\tau]$ for which $C_{\\text{ELF,free}}(t) > \\text{MIC}$, then the definition is:\n$$fT_{>\\text{MIC}} = \\frac{T_{>\\text{MIC}}}{\\tau}$$\nThe clinical target is given as $fT_{>\\text{MIC}} \\ge 0.50$. Substituting the definition of $fT_{>\\text{MIC}}$, this target becomes:\n$$\\frac{T_{>\\text{MIC}}}{\\tau} \\ge 0.50$$\n$$T_{>\\text{MIC}} \\ge 0.50 \\tau$$\nThis inequality demonstrates that the target $fT_{>\\text{MIC}} \\ge 0.50$ is mechanistically consistent with the requirement that the free drug concentration in the alveolar Epithelial Lining Fluid (ELF) must be maintained above the MIC for at least $50\\%$ of each dosing interval. Since bactericidal efficacy $E$ is an increasing function of $fT_{>\\text{MIC}}$, achieving a therapeutic threshold for $fT_{>\\text{MIC}}$ is a rational strategy for ensuring clinical effectiveness.\n\n**Task 2: Derivation of $fT_{>\\text{MIC}}$ at Steady State**\n\nWe model the system using a one-compartment model with first-order elimination following repeated intravenous bolus administration. The plasma concentration decays according to $C(t) = C_{peak} \\exp(-kt)$. At steady state, under a dosing regimen with interval $\\tau$, the concentration profile over one interval $t \\in [0, \\tau]$ (where $t=0$ is the time of the dose) is determined by the peak ($C_{ss,max}$) and trough ($C_{ss,min}$) concentrations.\n\nThe trough concentration is the concentration remaining from all prior doses. The peak concentration is the sum of the trough concentration and the concentration from the new dose, $D/V_d$:\n$$C_{ss,max} = C_{ss,min} + \\frac{D}{V_d}$$\nThe concentration decays over the interval, so the trough for the next interval is:\n$$C_{ss,min} = C_{ss,max} \\exp(-k\\tau)$$\nSolving these two simultaneous equations for $C_{ss,max}$:\n$$C_{ss,max} = C_{ss,max} \\exp(-k\\tau) + \\frac{D}{V_d}$$\n$$C_{ss,max} (1 - \\exp(-k\\tau)) = \\frac{D}{V_d}$$\n$$C_{ss,max} = \\frac{D}{V_d(1 - \\exp(-k\\tau))}$$\nThe plasma concentration at any time $t$ within the steady-state dosing interval is:\n$$C_{ss}(t) = C_{ss,max} \\exp(-kt) = \\frac{D}{V_d(1 - \\exp(-k\\tau))} \\exp(-kt)$$\nThe free concentration in the ELF is given by $C_{\\text{ELF,free}}(t) = f_u r C_{ss}(t)$:\n$$C_{\\text{ELF,free}}(t) = \\frac{f_u r D}{V_d(1 - \\exp(-k\\tau))} \\exp(-kt)$$\nThe duration $T_{>\\text{MIC}}$ is the time for which $C_{\\text{ELF,free}}(t) > \\text{MIC}$. We find the time point $t_{cross}$ where the concentration equals MIC. Assuming the peak is above MIC and the trough is below MIC, $T_{>\\text{MIC}} = t_{cross}$.\n$$C_{\\text{ELF,free}}(T_{>\\text{MIC}}) = \\text{MIC}$$\n$$\\frac{f_u r D}{V_d(1 - \\exp(-k\\tau))} \\exp(-kT_{>\\text{MIC}}) = \\text{MIC}$$\nSolving for $T_{>\\text{MIC}}$:\n$$\\exp(-kT_{>\\text{MIC}}) = \\frac{\\text{MIC} \\cdot V_d (1 - \\exp(-k\\tau))}{f_u r D}$$\n$$-kT_{>\\text{MIC}} = \\ln\\left(\\frac{\\text{MIC} \\cdot V_d (1 - \\exp(-k\\tau))}{f_u r D}\\right)$$\n$$T_{>\\text{MIC}} = \\frac{1}{k} \\ln\\left(\\frac{f_u r D}{\\text{MIC} \\cdot V_d (1 - \\exp(-k\\tau))}\\right)$$\nFinally, we obtain the expression for $fT_{>\\text{MIC}}$ by dividing by $\\tau$:\n$$fT_{>\\text{MIC}} = \\frac{T_{>\\text{MIC}}}{\\tau} = \\frac{1}{k\\tau} \\ln\\left(\\frac{f_u r D}{\\text{MIC} \\cdot V_d (1 - \\exp(-k\\tau))}\\right)$$\nThis is the required relationship at pharmacokinetic steady state.\n\n**Task 3: Calculation of Minimal Dosing Frequency**\n\nWe need to find the maximal dosing interval $\\tau$ that achieves the target $fT_{>\\text{MIC}} = 0.50$. Any higher frequency (smaller $\\tau$) will result in a greater or equal $fT_{>\\text{MIC}}$.\n$$0.50 = \\frac{1}{k\\tau} \\ln\\left(\\frac{f_u r D}{\\text{MIC} \\cdot V_d (1 - \\exp(-k\\tau))}\\right)$$\n$$0.50 k\\tau = \\ln\\left(\\frac{f_u r D}{\\text{MIC} \\cdot V_d (1 - \\exp(-k\\tau))}\\right)$$\n$$\\exp(0.50 k\\tau) = \\frac{f_u r D}{\\text{MIC} \\cdot V_d (1 - \\exp(-k\\tau))}$$\n$$\\exp(0.50 k\\tau)(1 - \\exp(-k\\tau)) = \\frac{f_u r D}{\\text{MIC} \\cdot V_d}$$\n$$\\exp(0.50 k\\tau) - \\exp(-0.50 k\\tau) = \\frac{f_u r D}{\\text{MIC} \\cdot V_d}$$\nThis equation is of the form $2 \\sinh(x) = A$, where $x = 0.50 k\\tau$ and $A = \\frac{f_u r D}{\\text{MIC} \\cdot V_d}$.\n$$2 \\sinh(0.50 k\\tau) = \\frac{f_u r D}{\\text{MIC} \\cdot V_d}$$\nSolving for $\\tau$:\n$$0.50 k\\tau = \\arcsinh\\left(\\frac{f_u r D}{2 \\cdot \\text{MIC} \\cdot V_d}\\right)$$\n$$\\tau = \\frac{2}{k} \\arcsinh\\left(\\frac{f_u r D}{2 \\cdot \\text{MIC} \\cdot V_d}\\right)$$\nNow, we substitute the given values:\n$D = 1.0 \\times 10^3 \\, \\mathrm{mg}$\n$V_d = 14 \\, \\mathrm{L}$\n$t_{1/2} = 2.0 \\, \\mathrm{h}$, so $k = \\frac{\\ln 2}{2.0} \\, \\mathrm{h}^{-1}$\n$f_u = 0.60$\n$r = 0.50$\n$\\text{MIC} = 2.0 \\, \\mathrm{mg/L}$\n\nLet's compute the argument of the $\\arcsinh$ function:\n$$\\frac{f_u r D}{2 \\cdot \\text{MIC} \\cdot V_d} = \\frac{(0.60)(0.50)(1.0 \\times 10^3 \\, \\mathrm{mg})}{2 (2.0 \\, \\mathrm{mg/L})(14 \\, \\mathrm{L})} = \\frac{300}{56} = \\frac{75}{14}$$\nNow, we find $\\tau$:\n$$\\tau = \\frac{2}{(\\ln 2) / (2.0 \\, \\mathrm{h})} \\arcsinh\\left(\\frac{75}{14}\\right) = \\frac{4.0}{\\ln 2} \\arcsinh\\left(\\frac{75}{14}\\right) \\, \\mathrm{h}$$\nThe minimal dosing frequency per day, $n$, is given by $n = \\frac{24 \\, \\mathrm{h}}{\\tau}$.\n$$n = \\frac{24}{\\frac{4.0}{\\ln 2} \\arcsinh\\left(\\frac{75}{14}\\right)} = \\frac{24 \\ln 2}{4.0 \\arcsinh\\left(\\frac{75}{14}\\right)} = \\frac{6 \\ln 2}{\\arcsinh\\left(\\frac{75}{14}\\right)} \\, \\mathrm{day}^{-1}$$\nWe now compute the numerical value:\n$$\\ln(2) \\approx 0.693147$$\n$$\\frac{75}{14} \\approx 5.357143$$\nUsing the identity $\\arcsinh(x) = \\ln(x + \\sqrt{x^2+1})$:\n$$\\arcsinh\\left(\\frac{75}{14}\\right) = \\ln\\left(\\frac{75}{14} + \\sqrt{\\left(\\frac{75}{14}\\right)^2 + 1}\\right) \\approx \\ln(5.357143 + \\sqrt{28.69898 + 1}) \\approx \\ln(5.357143 + 5.449677) \\approx \\ln(10.80682) \\approx 2.38018$$\n$$n = \\frac{6 \\times 0.693147}{2.38018} \\approx \\frac{4.158882}{2.38018} \\approx 1.74729 \\, \\mathrm{day}^{-1}$$\nRounding to three significant figures, the minimal dosing frequency is $1.75 \\, \\mathrm{day}^{-1}$. This corresponds to a maximal dosing interval of approximately $\\tau = 24/1.75 \\approx 13.7$ hours. A practical clinical regimen would likely be dosing every $12$ hours (twice per day) to ensure the target is met.",
            "answer": "$$\\boxed{1.75}$$"
        }
    ]
}